Dr. Rubin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5550 Caminito Genio
La Jolla, CA 92037Phone+1 858-736-7542
Education & Training
- Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1978 - 1979
- Duke University HospitalResidency, Internal Medicine, 1975 - 1978
- Albert Einstein College of MedicineClass of 1975
Certifications & Licensure
- NY State Medical License 2015 - 2026
- MD State Medical License 1985 - 2017
- NC State Medical License 1978 - 2017
- CA State Medical License 1999 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1995
Clinical Trials
- ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2004 Jan 01
- Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension Start of enrollment: 2006 Aug 01
Publications & Presentations
PubMed
- 35 citationsInhaled treprostinil: a therapeutic review.Richard N. Channick, Robert Voswinckel, Lewis J. Rubin
Drug Design, Development and Therapy. 2012-01-24 - 1878 citationsA Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionRobyn J. Barst, Lewis J. Rubin, Walker Long, Michael D. McGoon, Stuart Rich
The New England Journal of Medicine. 1996-02-01 - 419 citationsSurvival with first-line bosentan in patients with primary pulmonary hypertensionVv Mclaughlin, Olivier Sitbon, Db Badesch, Rj Barst, Carol Black
The European Respiratory Journal. 2005-02-01
Other
- Clinical features and diagnosis of pulmonary hypertension in adultsRubin LJ, Hopkins W
http://www.uptodate.com/contents/clinical-features-and-diagnosis-of-pulmonary-hypertension-in-adults
UpToDate, Wolters Kluwer Health - 2012-12-13 - Pathogenesis of pulmonary hypertensionRubin LJ, Hopkins W
http://www.uptodate.com/contents/pathogenesis-of-pulmonary-hypertension
UpToDate, Wolters Kluwer Health - 2012-10-22 - Treatment of pulmonary hypertension in adultsRubin LJ, Hopkins W
http://www.uptodate.com/contents/treatment-of-pulmonary-hypertension-in-adults
UpToDate, Wolters Kluwer Health - 2013-04-12 - Join now to see all
Press Mentions
- Karos Pharmaceuticals Advances Development of KAR5585 to Treat Pulmonary Arterial Hypertension into the ClinicApril 13th, 2016
- Pulmonary Hypertension Association (PHA) Names ‘Periwinkle Pioneers’: Honor Recognizes 25 Years of Pulmonary Hypertension (PH) AdvancementsNovember 25th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: